Results 281 to 290 of about 1,680,252 (377)

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug

open access: yesArthritis Care &Research, EarlyView.
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie   +3 more
wiley   +1 more source

Garder à tout prix, une tendance très tendance

open access: yesLa deuxième vie des objets - Anthropologie et sociologie des pratiques de récupérations, 2013
openaire   +1 more source

[Giant laterocervical lipoma in a 6-month-old infant: a case report]. [PDF]

open access: yesPan Afr Med J
Niang CD   +8 more
europepmc   +1 more source

Absolute Eosinophil Counts as a Prognostic Marker in Patients with Sepsis.

open access: yesAnn Afr Med
Shravani S   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy